CN Patent

CN104334165B — 用于治疗炎症和疼痛的药物组合物

Assigned to Olatec Therapeutics Inc · Expires 2017-09-05 · 9y expired

What this patent protects

本发明涉及药物组合物，包含药学可接受的载体和甲磺酰基烷基腈化合物，或者其药学可接受的盐或溶剂化物。本发明还涉及通过向有此需要的对象给药甲磺酰基烷基腈化合物或其药学可接受的盐或溶剂化物治疗炎症、炎症相关的病症或者疼痛的方法。

USPTO Abstract

本发明涉及药物组合物，包含药学可接受的载体和甲磺酰基烷基腈化合物，或者其药学可接受的盐或溶剂化物。本发明还涉及通过向有此需要的对象给药甲磺酰基烷基腈化合物或其药学可接受的盐或溶剂化物治疗炎症、炎症相关的病症或者疼痛的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104334165B
Jurisdiction
CN
Classification
—
Expires
2017-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Olatec Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.